Data / Drug companies / Allegiant Health
Allegiant Health: 113 products in the FDA NDC directory, labeler code 69168
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Allegiant Health (labeler code 69168) lists 113 products in the FDA National Drug Code Directory, covering 75 finished drugs by generic name. By type: 113 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on July 31, 2026.
The request: Watch Allegiant Health (FDA labeler code 69168): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 69168
- Products in commercial distribution
- 113
- Packages
- 280
- Finished drugs by generic name
- 75
- Prescription products
- 0
- Over the counter products
- 113
- Flagged as original packager
- 111 of 111 products that carry the flag
- Started marketing in the last 12 months
- 6
- Products with a marketing end date set
- 1
- Earliest marketing start
- November 30, 2000
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 72 | 63.7% |
| Generic drugs (ANDA) | 41 | 36.3% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 113 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 41 | 36.3% |
| Capsule, liquid filled | 11 | 9.7% |
| Tablet, coated | 8 | 7.1% |
| Spray, metered | 7 | 6.2% |
| Capsule | 7 | 6.2% |
| Tablet, film coated | 7 | 6.2% |
| Tablet, chewable | 6 | 5.3% |
| Liquid | 5 | 4.4% |
| Capsule, coated | 4 | 3.5% |
| Tablet, sugar coated | 3 | 2.7% |
| Solution/ drops | 3 | 2.7% |
| Tablet, extended release | 3 | 2.7% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Womens Laxative | 69168-490 | Tablet, sugar coated | Over the counter monograph drugs | July 31, 2026 |
| Laxative | 69168-489 | Tablet, sugar coated | Over the counter monograph drugs | July 31, 2026 |
| Eye Allergy Itch Relief | 69168-495 | Solution/ drops | Generic drugs (ANDA) | June 4, 2026 |
| Fluticasone Propionate | 69168-014 | Spray, metered | Generic drugs (ANDA) | April 30, 2026 |
| Daytime and Nighttime Cold and Flu Kit | 69168-013 | Kit | Over the counter monograph drugs | March 6, 2026 |
| Daytime Cold and Flu | 69168-474 | Capsule, liquid filled | Over the counter monograph drugs | January 9, 2026 |
| Carbamide peroxide 6.5% | 69168-488 | Solution/ drops | Over the counter monograph drugs | October 28, 2025 |
| Nighttime Sleep Aid | 69168-486 | Liquid | Over the counter monograph drugs | August 6, 2025 |
| Lidocaine Pain Relief | 69168-481 | Patch | Over the counter monograph drugs | July 31, 2025 |
| Triamcinolone acetonide | 69168-482 | Spray, metered | Generic drugs (ANDA) | July 30, 2025 |
| Cold Therapy Roll on | 69168-483 | Gel | Over the counter monograph drugs | July 29, 2025 |
| Tussin DM | 69168-477 | Liquid | Over the counter monograph drugs | July 23, 2025 |
| Rectal Care Cream | 69168-484 | Cream | Over the counter monograph drugs | July 7, 2025 |
| Esomeprazole Magnesium | 69168-472 | Capsule | Generic drugs (ANDA) | May 15, 2025 |
| Olopatadine hydrochloride | 69168-480 | Solution/ drops | Generic drugs (ANDA) | May 5, 2025 |
| Azelastine hydrochloride | 69168-479 | Spray, metered | Generic drugs (ANDA) | May 2, 2025 |
| Azelastine hydrochloride | 69168-478 | Spray, metered | Generic drugs (ANDA) | May 2, 2025 |
| Ibuprofen | 69168-466 | Tablet, film coated | Generic drugs (ANDA) | April 16, 2025 |
| Omeprazole | 69168-476 | Tablet, delayed release | Generic drugs (ANDA) | March 21, 2025 |
| Loratadine 10mg | 69168-475 | Tablet | Generic drugs (ANDA) | March 18, 2025 |
| Polyethylene Gycol 3350 | 69168-473 | Powder, for solution | Generic drugs (ANDA) | March 17, 2025 |
| Childrens Allergy Relief | 69168-471 | Liquid | Over the counter monograph drugs | January 7, 2025 |
| Menstrual complete | 69168-470 | Tablet, film coated | Over the counter monograph drugs | November 5, 2024 |
| Acid Reducer | 69168-445 | Tablet | Generic drugs (ANDA) | October 31, 2024 |
| Ibuprofen 200mg | 69168-467 | Tablet | Generic drugs (ANDA) | October 10, 2024 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.